Global Parkinson’s Disease Drugs Market Outlook, Analysis, Size, Share, Trends and Forecast 2017-2022
OrbisResearch.com has published new research report on “Global Parkinson’s Disease Drugs Market Research Report and Forecast to 2017-2022” to its database.
Dallas, United States – August 28, 2017 /MarketersMedia/ —
Parkinson’s disease belongs to the group of conditions called motor system disorders. This disease is a result of loss of dopamine producing neurons in the brain. The four primary symptoms of Parkinson’s disease are tremors, rigidity, slowness of movement and postural instability. Although, there is no cure for Parkinson’s disease, several medications are used to suppress the symptoms of the disease.
Browse the report: http://www.orbisresearch.com/reports/index/global-parkinsons-disease-drugs-market-outlook-2022
As per RNCOS report “Global Parkinson’s Disease Drugs Market Outlook 2022”, the global Parkinson’s disease drugs market is anticipated to witness a moderate growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global Parkinson’s disease drugs market. The report provides insight about the major drivers, such as increasing awareness about Parkinson’s disease and its treatment options, research grants and funds, for the global Parkinson’s disease drugs market.
Furthermore, few challenges, such as patent expiry and high cost of treatment, which are hindering the growth of the global Parkinson’s disease drugs market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Parkinson’s disease drugs market.
The global Parkinson’s disease drugs market has been segmented on the basis of type of therapy into levodopa therapy, dopamine therapy, MAO-B inhibitor therapy, COMT inhibitor therapy, and other types of therapies. Among all the types, levodopa therapy is the first and most potent treatment for the Parkinson’s disease. The benefits of the medication are witnessed soon after administration.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/391560
Apart from these types of therapies, various pharmaceutical and biotech companies are also developing stem cell therapy for the treatment of Parkinson’s disease. Stem cell therapy is an evolving field which makes use of stem cells to treat or prevent a disease or condition, such as Parkinson’s disease. Even a minimal success from this procedure can mean significant improvement in quality of life for patients.
Numerous companies, such as SanBio Inc and International Stem Cell Corp, are carrying out clinical trials for stem cell therapies for the treatment of Parkinson’s disease. Hence, stem cell therapy presents great opportunities for the growth of global Parkinson’s disease drugs market in the coming years.
Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global Parkinson’s disease drugs market. Moreover, the report also highlights various mergers and acquisitions taking place in the global Parkinson’s disease drugs industry. The drugs pipeline of Parkinson’s disease has also been mentioned in the report.
The last section of the report discusses about the prominent players in global Parkinson’s disease drugs market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios and product pipeline. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Parkinson’s disease drugs market.
Buy the report@http://www.orbisresearch.com/contact/purchase/391560
Major Points From The Table Of Contents:
Analyst View
Research Methodology
Parkinson’s Disease: An Overview
Market Dynamics
Market Segmentation by Type of Therapy
Market Segmentation by Geography
Trends & Developments
Mergers & Acquisitions
Drugs Pipeline of Parkinson’s Disease
Company Profiles(Abbvie Inc., Newron Pharmaceuticals SpA, Acadia Pharmaceuticals Inc., GlaxoSmithKline plc, UCB S.A. and So on..)
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817
For more information, please visit http://www.orbisresearch.com/reports/index/global-parkinsons-disease-drugs-market-outlook-2022
Source: MarketersMedia
Release ID: 233542
Copyright © 1999-2013 SproutNews.com
